Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates

Acadia Pharmaceuticals (ACAD) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this drugmaker would post earnings of $0.1 per share when it actually produced earnings of $0.11, delivering a surprise of +10%.Over the last four quarters, the co ...